Trial Site Detail

 

Drug:
Regorafenib + Avelumab
Trial:
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (REGOMUNE)
Conditions: Solid Tumors
Trial Status:
Recruiting

 

Centre Régional de Lutte contre le Cancer de Montpellier

     
Montpellier , Herault 34298
France

 

Principal Investigator:
Contact:
Antoine Adenis, MD, PhD
Activation Status of this Site:
Active
Notes about this Site:
Centre Régional de Lutte contre le Cancer de Montpellier Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.